Long-lived mammals exhibit greater evolutionary conservation at cancer-associated loci and a pronounced enrichment of m6A modifications at those same loci, suggesting that enhanced sequence conservation coupled with targeted mRNA methylation may be part of a multilayered molecular strategy that reduces cancer risk in long-lived mammals.
Key Findings
Results
Overall evolutionary rates at cancer-associated loci do not differ significantly between long-lived and short-lived mammalian species.
The study examined evolutionary rates of human cancer-associated sites across 58 mammalian species.
No significant difference in overall evolutionary rates at cancer-associated loci was detected when comparing long-lived versus short-lived species.
This finding indicates that simple acceleration or deceleration of evolution genome-wide at cancer loci does not explain the cancer resistance of long-lived species.
Results
Cancer-associated sites show greater evolutionary conservation relative to non-cancer sites within long-lived mammals but not within short-lived mammals.
The comparison was made between cancer-associated loci and non-cancer sites within each longevity group.
This pattern of enhanced relative conservation at cancer loci was specific to long-lived species.
Short-lived mammals did not exhibit a similar relative conservation pattern at cancer-associated loci.
This differential conservation suggests a longevity-linked selective pressure acting specifically on cancer-relevant genomic regions.
Results
Long-lived species exhibit a pronounced enrichment of m6A modifications at cancer-associated loci despite having lower global m6A levels.
m6A modification sites used in the analysis were derived exclusively from male samples.
The enrichment of m6A at cancer-associated loci in long-lived species occurs against a background of lower overall m6A levels compared to short-lived species.
This pattern implies a targeted rather than global increase in m6A methylation at cancer-relevant transcripts in long-lived mammals.
The study examined 58 mammalian species for this epigenetic analysis.
Results
Tumor suppressor genes in long-lived mammals harbor proportionally more m6A-modified transcripts than in short-lived mammals.
The enrichment of m6A at tumor suppressor gene transcripts suggests a potential association between mRNA methylation and post-transcriptional regulation at cancer-relevant loci.
This finding connects the epigenetic modification pattern specifically to the class of genes with cancer-protective function.
The result was observed within the broader context of lower global m6A levels in long-lived species, highlighting the site-specific nature of the modification.
Background
The study addresses Peto's paradox by identifying molecular mechanisms potentially linking longevity to reduced cancer risk in large, long-lived mammals.
Peto's paradox refers to the puzzling disconnect between organismal lifespan, body size, and cancer incidence.
The authors propose that enhanced sequence conservation at cancer loci, coupled with targeted mRNA modification, may constitute a 'multilayered molecular strategy that reduces cancer risk in long-lived mammals.'
The framework integrates both evolutionary (sequence conservation) and epigenetic (m6A modification) levels of regulation.
58 mammalian species were compared to assess these patterns across diverse taxa.
What This Means
This research suggests that long-lived mammals have evolved at least two distinct molecular strategies to protect cancer-associated genes. First, the DNA sequences of cancer-related genes are more conserved (i.e., change less over evolutionary time) in long-lived species compared to non-cancer genes, a pattern not seen in short-lived species. This implies that natural selection has been particularly strict about maintaining the integrity of cancer-relevant genes in animals that live longer. Second, long-lived species show a targeted increase in a specific chemical modification on RNA molecules—called m6A methylation—precisely at the transcripts of cancer-associated genes, including tumor suppressor genes, even though these animals have lower levels of this modification across the genome as a whole.
These findings are relevant to understanding Peto's paradox—the observation that large, long-lived animals like elephants and whales do not get cancer at higher rates than smaller, shorter-lived animals despite having far more cells that could potentially become cancerous. This study suggests that the answer may involve both evolutionary and epigenetic (chemical) layers of regulation acting together on the same cancer-related genes. The m6A modification at tumor suppressor transcripts could help regulate how those protective genes are processed after they are transcribed, potentially keeping them more tightly controlled.
This research suggests that cancer resistance in long-lived mammals is not a simple or single mechanism, but rather a combination of preserved DNA sequences and targeted chemical regulation of RNA. Understanding these strategies in naturally cancer-resistant animals could inform future research into cancer biology more broadly, though the findings are correlational and the functional consequences of these patterns would need further experimental validation.
Zhang X, Li M, Tong X, Chen W, Liu G, Zhu P, et al.. (2026). Longer-lived mammals exhibit greater evolutionary conservatism and epigenetic modification at cancer-associated loci.. Nature communications. https://doi.org/10.1038/s41467-026-76479-3